Related Experiment Video
Updated: Jul 29, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Association between mannose binding lectin gene polymorphisms and clinical severity of COVID-19 in children
Dilek Yilmaz1,2, Mustafa Soyoz3, Aslıhan Sahin4
1Department of Pediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey.
Background:
Mannose-binding lectin (MBL) is a member of innate immunity and acts with MASP (MBL-associated serine protease) to activate the lectin pathway of the complement system. MBL gene polymorphisms are associated with susceptibility to infectious diseases. This study investigated whether MBL2 genotype, serum MBL levels, and serum MASP-2 levels affect the course of SARS-CoV-2 infection.
Methods And Results:
Pediatric patients diagnosed with COVID-19 by positive real-time polymerase chain reaction (PCR) were included in the study. Single nucleotide polymorphisms in the promoter and exon 1 in the MBL2 gene (rs11003125, rs7096206, rs1800450, rs1800451, rs5030737) were identified by a PCR and restriction fragment length polymorphisms analysis. Serum MBL and MASP-2 levels were measured by ELISA. COVID-19 patients were divided into asymptomatic and symptomatic. Variables were compared between these two groups. A total of 100 children were included in the study. The mean age of the patients was 130 ± 67.2 months. Of the patients, 68 (68%) were symptomatic, and 32 (32%) were asymptomatic. The polymorphisms in the - 221nt and - 550nt promoter regions did not differ between groups (p > 0.05). All codon 52 and codon 57 genotypes were determined as wild-type AA. AB genotypes were found 45.6% in symptomatic patients while 23.5% in asymptomatics. Moreover, BB genotype was detected 9.4% in symptomatic and 6.3% in asymptomatic patients (p < 0.001). B allele was more frequent in symptomatic patients (46.3%) compared to asymptomatic patients (10.9%). (p < 0.001). Serum MBL and MASP-2 levels did not differ statistically between the groups (p = 0.295, p = 0.073).
Conclusion:
These findings suggest that codon 54 polymorphism in the MBL2 gene exon-1 region can be associated with the symptomatic course of COVID-19.
Insights
Mannose-binding lectin (MBL) gene polymorphisms, specifically in the MBL2 exon-1 region, are linked to the severity of COVID-19 in children. The study found a higher frequency of certain MBL2 genotypes in symptomatic pediatric COVID-19 patients.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Mannose-binding lectin (MBL) is a key component of innate immunity, activating the complement system's lectin pathway with MBL-associated serine proteases (MASPs).
- MBL gene variations are known risk factors for infectious disease susceptibility.
- The role of MBL and MASP-2 in SARS-CoV-2 infection severity requires further investigation.
Purpose of the Study:
- To investigate the association between MBL2 gene polymorphisms, serum MBL levels, and serum MASP-2 levels with the clinical course of COVID-19 in pediatric patients.
- To compare these factors between asymptomatic and symptomatic children with COVID-19.
Main Methods:
- Genotyping of MBL2 gene single nucleotide polymorphisms (SNPs) in promoter and exon 1 regions using PCR and restriction fragment length polymorphism analysis.
- Quantification of serum MBL and MASP-2 levels via ELISA.
- Comparison of genetic and serological data between symptomatic and asymptomatic pediatric COVID-19 cases.
Main Results:
- No significant differences in MBL2 promoter region polymorphisms (rs11003125, rs7096206) between symptomatic and asymptomatic groups.
- Codon 52 and 57 genotypes were predominantly wild-type AA in all patients.
- A significantly higher prevalence of MBL2 exon-1 AB and BB genotypes, and B allele, was observed in symptomatic pediatric COVID-19 patients compared to asymptomatic ones (p < 0.001).
- Serum MBL and MASP-2 levels did not show significant differences between the groups.
Conclusions:
- Codon 54 polymorphism in the MBL2 gene exon-1 region is associated with a symptomatic course of COVID-19 in children.
- MBL2 genotype, not serum MBL or MASP-2 levels, appears to influence COVID-19 symptom severity in the pediatric population studied.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
13:36Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Proteoglycans
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...